EFPIA Newsletter 16 February 2017

16 February 2017

News     15 February 2017 20170215 EFPIA Welcomes the European Parliament’s green light to CETA Read more →         16 February 2017 20170216 EBE and EFPIA Support ARM Initiative on Hospital Exemptions and Call for Increased... Read more →

Events calendar     28 MAR 2017   DIA BioVenture Day Glasgow, UK Is the current Bioventure paradigm delivering return for patients and investors?" is the key question to be addressed... Learn more →       29 MAR 2017   DIA EuroMeeting 2017 Glasgow, UK DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide... Learn more →

	06 JUN 2017			170609 Certificate in Healthcare Compliance Ethics & Regulation Paris, France A whole week into the legal framework of healthcare industries Learn more →

	04 APR 2017			20170404 Biovision World Life Science Forum Lyon, France This year, the forum will welcome major players from the health sector representing each step of the value chain with... Learn more →

Documents Position paper: Optimising Post-Approval Change Management for Timely Access to Medicinal Worldwide Post-approval changes (PACs) to the registered information of authorised medicinal products, hereafter referred to as ‘variations’, are introduced routinely worldwide to: enhance the robustness and [...] Read more

What we are reading Shout about the European Union’s success 16 February 2017  (Nature) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe